Isabelle Zenklusen

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Atrial Fibrillation

Direct Oral Anticoagulants

Top Venues

Clinical and experimental pharmacology & physiology

Expert opinion on drug metabolism & toxicology

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Isabelle Zenklusen, Jasper Dingemanse, Christian Reh, Martine Géhin, Priska Kaufmann
Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects. Drugs in R&D (2024)
Isabelle Zenklusen, Jasper Dingemanse, Christian Reh, Martine Géhin, Priska Kaufmann
Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects. Drugs in R&D 24 (1) (2024)
Isabelle Zenklusen, Jasper Dingemanse, Christian Reh, Martine Géhin, Priska Kaufmann
Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects. Drugs in R&D 24 (1) (2024)
Isabelle Zenklusen, Jasper Dingemanse, Christian Reh, Martine Géhin, Priska Kaufmann
Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects. Drugs in R&D 24 (1) (2024)
Isabelle Zenklusen, Jasper Dingemanse, Christian Reh, Martine Géhin, Priska Kaufmann
Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects. Drugs in R&D 24 (1) (2024)
Isabelle Zenklusen, Chih-Hsuan Hsin, Uta Schilling, Martin Kankam, Andreas Krause, Mike Ufer, Jasper Dingemanse
Transition from Syringe to Autoinjector Based on Bridging Pharmacokinetics and Pharmacodynamics of the P2Y 12 Receptor Antagonist Selatogrel in Healthy Subjects. Clinical pharmacokinetics 61 (5) (2021)
Isabelle Zenklusen, Clemens Muehlan, Ivan Ulc, Jiří Liška, Jasper Dingemanse
The dual orexin receptor antagonist daridorexant does not affect the pharmacokinetics of the BCRP substrate rosuvastatin. Clinical and experimental pharmacology & physiology 47 (11) (2020)
Clemens Muehlan, Cedric Vaillant, Isabelle Zenklusen, Stephan Kraehenbuehl, Jasper Dingemanse
Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders. Expert opinion on drug metabolism & toxicology 16 (11) (2020)